特定タンパク質検査:医療機器パイプライン分析2020

GlobalDataが発行した調査報告書(GD21MC030)
◆英語タイトル:Specific Proteins Tests - Medical Devices Pipeline Assessment, 2020
◆商品コード:GD21MC030
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年11月30日
◆ページ数:86
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Specific Proteins Tests – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Specific Proteins Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Specific Proteins Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Specific Proteins Test kits which are used to quantify and detect protein molecules from bodily fluids. immunoglobulins (without IgE), HAMA, Immunoelectrophoresis & immunofixation kits, complement components, transport proteins, lipoproteins, AGP, AAT, micro and macro G etc.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Specific Proteins Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Specific Proteins Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Specific Proteins Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Specific Proteins Tests Overview
3 Products under Development
3.1 Specific Proteins – Pipeline Products by Stage of Development
3.2 Specific Proteins – Pipeline Products by Territory
3.3 Specific Proteins – Pipeline Products by Regulatory Path
3.4 Specific Proteins – Pipeline Products by Estimated Approval Date
4 Specific Proteins – Pipeline Products under Development by Companies
4.1 Specific Proteins Companies – Pipeline Products by Stage of Development
4.2 Specific Proteins – Pipeline Products by Stage of Development
5 Specific Proteins Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.2 Alfa Wassermann Diagnostic Technologies, LLC Company Overview
5.3 Amerimmune LLC Company Overview
5.4 Beckman Coulter Inc Company Overview
5.5 China Medical Technologies Inc (Inactive) Company Overview
5.6 Colorado State University Company Overview
5.7 Fujirebio Diagnostics Inc Company Overview
5.8 Genesis Detection Systems, Inc. Company Overview
5.9 Genome Diagnostics Pvt Ltd Company Overview
5.10 Guanine Inc Company Overview
5.11 Hologic Inc Company Overview
5.12 Isoformix Inc Company Overview
5.13 Kobe University Company Overview
5.14 Ortho-Clinical Diagnostics Inc Company Overview
5.15 Ottawa Hospital Research Institute Company Overview
5.16 Roche Diagnostics International Ltd Company Overview
5.17 Sebia SA Company Overview
5.18 Siemens Healthcare Diagnostics Inc Company Overview
5.19 SomaLogic Inc Company Overview
5.20 The Binding Site Group Ltd Company Overview
5.21 Umea University Company Overview
5.22 University of California Company Overview
6 Specific Proteins- Recent Developments
6.1 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.2 Jul 02, 2020: Svar Flexi Solutions – Products for your flexible assay setup
6.3 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.4 May 06, 2020: LakePharma supplying Mount Sinai with SARS-CoV-2 proteins for serological assays
6.5 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.6 Feb 26, 2020: bioMerieux – 2019 financial results
6.7 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.8 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.9 Jan 27, 2020: PerkinElmer announces financial results for the fourth quarter
6.10 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.11 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.12 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Specific Proteins - Pipeline Products by Stage of Development
Table 2: Specific Proteins - Pipeline Products by Territory
Table 3: Specific Proteins - Pipeline Products by Regulatory Path
Table 4: Specific Proteins - Pipeline Products by Estimated Approval Date
Table 5: Specific Proteins Companies - Pipeline Products by Stage of Development
Table 6: Specific Proteins - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Alinity c Assay - Cystatin C - Product Status
Table 9: Alinity c Assay - Cystatin C - Product Description
Table 10: Alinity c Assay - Immunoglobulin E - Product Status
Table 11: Alinity c Assay - Immunoglobulin E - Product Description
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ACE Axcel System - Lp(a) Assay - Product Status
Table 14: ACE Axcel System - Lp(a) Assay - Product Description
Table 15: ACE Axcel System - Microalbumin Assay - Product Status
Table 16: ACE Axcel System - Microalbumin Assay - Product Description
Table 17: ACE Axcel System - Transferrin Assay - Product Status
Table 18: ACE Axcel System - Transferrin Assay - Product Description
Table 19: Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: FoxP3 Protein Expression Assay - Product Status
Table 21: FoxP3 Protein Expression Assay - Product Description
Table 22: Wiscott-Aldrich Protein Expression Assay - Product Status
Table 23: Wiscott-Aldrich Protein Expression Assay - Product Description
Table 24: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Access - sFlt-1 Assay - Product Status
Table 26: Access - sFlt-1 Assay - Product Description
Table 27: UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 28: UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 29: UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Status
Table 30: UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Description
Table 31: UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 32: UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 33: UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Status
Table 34: UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Description
Table 35: UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 36: UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 37: UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Status
Table 38: UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Description
Table 39: UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 40: UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 41: UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Status
Table 42: UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Description
Table 43: UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Status
Table 44: UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Description
Table 45: UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 46: UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 47: UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Status
Table 48: UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Description
Table 49: UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Status
Table 50: UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Description
Table 51: UniCel DxI 860i Synchron Access Clinical System - PlGF Assay - Product Status

List of Figures
Figure 1: Specific Proteins - Pipeline Products by Stage of Development
Figure 2: Specific Proteins - Pipeline Products by Territory
Figure 3: Specific Proteins - Pipeline Products by Regulatory Path
Figure 4: Specific Proteins - Pipeline Products by Estimated Approval Date

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 特定タンパク質検査:医療機器パイプライン分析2020(Specific Proteins Tests - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆